Naratriptan and Levothyroxine sodium drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Naratriptan (naratriptan) and Levothyroxine sodium (levothyroxine sodium). Common drug interactions include cough among females and small for dates baby among males.

The phase IV clinical study analyzes what interactions people have when they take Naratriptan and Levothyroxine sodium. It is created by eHealthMe based on reports of 21 people who take the same drugs from the FDA, and is updated regularly.

What is Naratriptan?

Naratriptan has active ingredients of naratriptan. It is often used in migraine. eHealthMe is studying from 1,481 Naratriptan users. Check the latest studies of Naratriptan.

What is Levothyroxine sodium?

Levothyroxine sodium has active ingredients of levothyroxine sodium. It is often used in hypothyroidism. eHealthMe is studying from 129,812 Levothyroxine sodium users. Check the latest studies of Levothyroxine sodium.



On Jul, 06, 2026

21 people who take Naratriptan and Levothyroxine sodium together, and have interactions are studied.

Naratriptan and Levothyroxine sodium drug interactions.

What are the common drug interactions of Naratriptan and Levothyroxine Sodium, by gender? *:

female:

  1. Cough
  2. Feeling cold
  3. Headache (pain in head)
  4. Hypertension (high blood pressure)
  5. Hypotension (abnormally low blood pressure)
  6. Joint range of motion decreased (disease of joint movement)
  7. Listless (lack of interest, energy, or spirit)
  8. Muscular weakness (muscle weakness)
  9. Nail disorder (disease of nail)
  10. Nasopharyngitis (inflammation of the nasopharynx)

male:

  1. Small for dates baby (an unborn baby is growing more slowly and is smaller than most babies are at the same age)
  2. Foetal exposure during pregnancy (exposing your unborn child to contraindicated in pregnancy leads birth defect)

What are the common drug interactions of Naratriptan and Levothyroxine Sodium, by age (0-1 to 60+)? *:

0-1:

  1. Small for dates baby (an unborn baby is growing more slowly and is smaller than most babies are at the same age)
  2. Foetal exposure during pregnancy (exposing your unborn child to contraindicated in pregnancy leads birth defect)

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Blood potassium decreased
  2. Food craving
  3. Oedema peripheral (superficial swelling)
  4. Salt craving
  5. Vasculitis (inflammation of a blood vessel or blood vessels)
  6. Weight increased

40-49:

  1. Fatigue (feeling of tiredness)
  2. Asthenia (weakness)
  3. Cardiac murmur (an heart sound in valve abnormality)
  4. Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
  5. Cough
  6. Feeling cold
  7. Headache (pain in head)
  8. Hypertension (high blood pressure)
  9. Hypoaesthesia (reduced sense of touch or sensation)
  10. Hypotension (abnormally low blood pressure)

50-59:

  1. Drug ineffective
  2. Thrombosis (formation of a blood clot inside a blood vessel)

60+:

  1. Abdominal pain
  2. Candidiasis (candidiasis or thrush is a fungal infection)
  3. Abdominal symptom
  4. Alanine aminotransferase increased
  5. Aspartate aminotransferase increased
  6. C-reactive protein increased
  7. Faecaloma (hard mass of fecal matter)
  8. Gastrointestinal necrosis (destruction of gastrointestinal organ)
  9. Intestinal ischaemia (decreased supply of oxygenated blood to the intestines)
  10. Intestinal obstruction

What are the existing conditions these people have? *

  1. Depression: 5 people, 23.81%
  2. Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 4 people, 19.05%
  3. Nausea (feeling of having an urge to vomit): 4 people, 19.05%
  4. Chronic Thyroiditis (long lasting inflammation of thyroid gland): 3 people, 14.29%
  5. Thyroid Diseases: 2 people, 9.52%

* Approximation only. Some reports may have incomplete information.

Do you take Naratriptan and Levothyroxine sodium?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Naratriptan and Levothyroxine sodium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Naratriptan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Levothyroxine sodium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Naratriptan and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Levothyroxine sodium and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on naratriptan and levothyroxine sodium (the active ingredients of Naratriptan and Levothyroxine sodium, respectively), and Naratriptan and Levothyroxine sodium (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: